New Influenza A (H1N1) Vaccine: Sartorius Stedim Biotech Receives Significant Additional Orders from Leading Vaccine Producers

GOETTINGEN, Germany--(BUSINESS WIRE)--Regulatory News: Sartorius Stedim Biotech (SSB)(Paris:DIM), a leading international supplier for the pharma and biotech industries, lately received several large orders for consumables used in biopharmaceutical production from leading global vaccine manufacturers. They primarily ordered specialty filters, aseptic single-use bags and other disposables for sterile filtration of pharmaceutical liquids and for storage and transport of intermediate serum products. These products are high margin within the SSB’s product array. The orders received and the further ones expected will likely add more than one percentage point to Sartorius Stedim Biotech’s annual sales and contribute overproportionately to its profit.
MORE ON THIS TOPIC